Scientists at Memorial Sloan Kettering Cancer Center (MSK) have developed Spectra, an open-source computational method that they say improves the analysis of single-cell transcriptomic data. Spectra enables researchers to identify functionally relevant gene expression programs, particularly those that are novel or highly specific to a biological context. It is well-suited for large patient cohorts and holds promise for identifying biomarkers and drug targets in immuno-oncology. Spectra has been made freely available to researchers worldwide.
The single-cell revolution has transformed the study of health and disease by enabling researchers to investigate individual cells in tissue samples and understand the activity of genes in each cell. However, the vast amount of data generated by single-cell methods can be challenging to interpret, particularly when analyzing gene programs active across multiple cell types. Spectra addresses these issues by guiding data analysis using existing scientific knowledge and adapting to the specific dataset. The method is particularly useful for studying interactions between cell types with overlapping gene programs, such as those between cancer cells and immune cells.
Search Antibodies Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.
The MSK research team used Spectra to analyze breast cancer immunotherapy data and a lung cancer atlas, totaling over 1.5 million cells from 375 individuals in 21 studies. Spectra's ability to overcome traditional analysis limitations is demonstrated in the paper published in Nature Biotechnology.
Spectra's innovative design also considers information about genes defining different cell types, enabling it to identify gene programs underlying cellular functions. It can distinguish between exhausted T cells and tumor-reactive T cells, making it valuable for studying complex environments like the tumor microenvironment. Additionally, Spectra streamlines data analysis and knowledge transfer across single-cell sequencing studies. The team hopes it can be used to provide new insights into complex cellular interactions and help accelerate the discovery of biomarkers and drug targets.